Coronavirus News Roundup: Pharmacists Can Improve Vaccine Uptake; FDA and CDC Recommend Pause for Johnson & Johnson Vaccine
Here's a roundup of the latest coronavirus-related news.
As the United States nears the 200 million mark for the total number of COVID-19 vaccine doses administered, with 23.5% of Americans fully vaccinated against the virus as of April 15, coronavirus-related news is not slowing down.
Here’s a roundup of the latest coronavirus-related news, including a recent survey from the National Community Pharmacists Assocation (NCPA) and the CDC recommendation to temporarily pause the Johnson & Johnson vaccine.
NCPA: Independent Pharmacies Can Improve Vaccine Uptake in Vulnerable Communities
According to a new survey from the National Community Pharmacists Association (NCPA), independent community pharmacists are key to vaccinating socially vulnerable populations, including minority populations, but many are receiving inadequate vaccine supply.
Guillain-Barré Syndrome in COVID-19 Vaccine Trial Does Not Imply Causality, Experts Say
In a COVID-19 vaccine trial, an individual who received the vaccine subsequently developed Guillain-Barré syndrome; however, authors of a recently published paper are cautioning that this does not prove that the vaccine was the cause.
FDA, CDC Recommend Temporary Pause for Johnson & Johnson COVID-19 Vaccine
US health officials are recommending a pause in the administration of the single-dose Johnson & Johnson COVID-19 vaccine following 6 reports of a rare and severe type of blood clot, according to a joint statement issued on Tuesday by the CDC and FDA.
Study: Some Individuals Report Long-Term Effects Following Mild COVID-19
Although it is known that many patients hospitalized with COVID-19 report persistent long-term symptoms, there is not much knowledge regarding long-term outcomes among individuals with mild COVID-19.
What Contributes to Severe COVID-19 in Kids
COVID-19 may be mild in most cases for children, but severe cases do happen. An investigation offers insight into what factors may contribute to those cases.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
